Assessing the Value of Antipsychotics for Treating Schizophrenia
Authors:
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 22 (1) , 1-8
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Olanzapine versus Risperidone in the Treatment of SchizophreniaPharmacoEconomics, 2003
- The Impact of Health Economics on Healthcare DeliveryPharmacoEconomics, 2000
- The use of atypical antipsychotics in the management of schizophreniaBritish Journal of Clinical Pharmacology, 1999
- Clinical and Economic Outcomes of Olanzapine Compared With Haloperidol for SchizophreniaPharmacoEconomics, 1999
- Cost Analysis of the Treatment of Schizophrenia in the UKPharmacoEconomics, 1998
- Economic Considerations and Formulary Management of Oral AntipsychoticsDisease Management and Health Outcomes, 1998
- Some Aspects of the Cost of Schizophrenia in FrancePharmacoEconomics, 1997
- Medical Comorbidity in SchizophreniaSchizophrenia Bulletin, 1996
- Medical Comorbidity and Schizophrenia: Editors' IntroductionSchizophrenia Bulletin, 1996
- Measuring the Costs of SchizophreniaPharmacoEconomics, 1995